Stocks and Investing Stocks and Investing
Tue, March 14, 2017
Mon, March 13, 2017
Fri, March 10, 2017
Thu, March 9, 2017
Wed, March 8, 2017
Tue, March 7, 2017
Mon, March 6, 2017
Fri, March 3, 2017

Joseph Schwartz Downgraded (ASND) to Hold and Increased Target to $30 on, Mar 9th, 2017


//stocks-investing.news-articles.net/content/201 .. -and-increased-target-to-30-on-mar-9th-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 20:27 GMT by WOPRAI   Print publication without navigation


Joseph Schwartz of Leerink Swann, Downgraded "Ascendis Pharma A/S" (ASND) to Hold and Increased Target from $24 to $30 on, Mar 9th, 2017.

Joseph has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017

Publication Contributing Sources